TEAGAN CHARLES: Open Payments
NPI 1609366921 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,422 in 190 payments from 24 companies in 2025. Trend: 2023 $4,149 · 2024 $5,080 · 2025 $4,422
Food & beverage: $4,141Education: $281
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 24 | $953 |
| UCB, Inc. | 16 | $585 |
| Janssen Biotech, Inc. | 20 | $515 |
| Incyte Corporation | 13 | $301 |
| ABBVIE INC. | 11 | $213 |
| PFIZER INC. | 9 | $202 |
| Regeneron Healthcare Solutions, Inc. | 10 | $162 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 14 | $160 |
| Amgen Inc. | 9 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $140 |
Products named: NEMLUVIO, Bimzelx, TREMFYA, DUPIXENT, CIBINQO, SKYRIZI, OPZELURA, JUBLIA.
Industry payments across TX — which companies pay providers there.
